Common Contracts
10 similar Collaborative Agreement contracts by Osi Pharmaceuticals Inc, Ariad Pharmaceuticals Inc, Corvas International Inc, others
EXHIBIT 10.56 COLLABORATIVE AGREEMENTCollaborative Agreement • August 14th, 2001 • Corvas International Inc • Pharmaceutical preparations • Delaware
CONFIDENTIAL TREATMENT REQUESTEDCollaborative Agreement • April 9th, 2001 • Diadexus Inc • Services-commercial physical & biological research • Delaware
TEXT OMITTED AND FILED SEPARATELY CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406Collaborative Agreement • February 21st, 2001 • Senomyx Inc • California
1 Exhibit 10.52 HEADS OF AGREEMENT: IMMUNOGEN /GENENTECH COLLABORATIVE AGREEMENT A. EFFECTIVE DATE: The effective date of this Heads of Agreement ("HEADS OF AGREEMENT") shall be as of May 2, 2000 (the "EFFECTIVE DATE"). B. PARTIES: The parties to this...Collaborative Agreement • September 27th, 2000 • Immunogen Inc • Pharmaceutical preparations
andCollaborative Agreement • August 16th, 1999 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
AMENDMENT NO. 1 to the Collaborative Agreement dated as of April 19, 1995 between Novartis Pharma AG and OSI Pharmaceuticals, Inc.Collaborative Agreement • August 16th, 1999 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
ARTICLE 2 INITIAL EQUIPMENT LEASEDCollaborative Agreement • April 6th, 1999 • Surgical Safety Products Inc • Services-misc health & allied services, nec • Florida
EXHIBIT 10.28Collaborative Agreement • May 13th, 1997 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
EISAI/PARAVAX COLLABORATIVE AGREEMENT JANUARY 1993 2 AGREEMENTCollaborative Agreement • April 24th, 1997 • Heska Corp
BETWEENCollaborative Agreement • December 20th, 1995 • Oncogene Science Inc • In vitro & in vivo diagnostic substances • New York
